United States· US:54859-605_47462c1c-38e8-e1af-e063-6394a90a4955
Tusnel Pediatric Drops
A medicinal product containing guaifenesin; phenylephrine hydrochloride, registered in United States by LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
- Manufacturer
- LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11548596050130 mL in 1 BOTTLE, DROPPER (54859-605-01)
- ndc1154859-605-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd3a7789-6b06-40f1-b0ea-265d3a19d0a9 GET /v1/drugs/fd3a7789-6b06-40f1-b0ea-265d3a19d0a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "25; 1.25",
"substance": "GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE",
"productndc": "54859-605",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about guaifenesin; phenylephrine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.